2021年1月31日星期日

Tonight’s Deadline: 5 Stocks Set to Double

Zacks | Our Research. Your Success.

Invitation to Access Expires at Midnight

Zacks Member,

Haven't heard from you about my Thursday email so I'm following up with an important message . . .

Today you can still beat the deadline to download our Special Report, 5 Stocks Set to Double.

Remember, these 5 were selected from thousands of companies. Each is the single favorite stock of a Zacks expert who gives it the best chance to gain +100% and more in the months ahead.

Previous editions of this report have racked up some huge gains. Examples include Boston Beer Co. which soared +143.0%, Nvidia blasted +175.9%, Weight Watchers climbed +498.3%, and Tesla surged +673%

Before word spreads too far, tomorrow morning looks like a very good time to buy these companies:

Stock #1 - Shares of this Growing Tech Company Gained +113% Since March 2020. An American tech developer, with products already available in the Apple App Store and Google Play, that's pairing the prevalence of smartphone use with another sustainable growth industry. Fueled by a record quarter in Q3 2020, its shares have gained 270% over the last five years with more upside ahead.

Stock #2 - Asian Company Controlling 80% of E-Comm's Market Share. With a seemingly endless number of digital products available, this multinational company is the most profitable in China. It controls 80% of e-comm's market share, and for the next few years, has a more extensive revenue growth outlook than Amazon. It has a massive amount of growth potential, and 15 out of 15 analysts call this a buy today.

Stock #3 - Domestic Well-Diversified Construction Company on the Rise. This diversified construction company specializes in providing various services for the traditional power, civil infrastructure, and renewable energy industries. Last quarter, the company doubled Zacks earnings per share estimates, and it's poised to benefit significantly from the clean energy plan to be initiated by the new presidential administration.

Stock #4 - Small-Cap Biotech Company Poised for Explosive Growth. An emerging player in the field of central nervous system disorders, this biopharmaceutical company focuses on treating certain neurological diseases using its innovative proprietary platform. Analysts are already bullish due to the company's potential for treating Alzheimer's and Rett syndrome.

Stock #5 - Renowned Omnichannel Retailer Wisely Pivots During Pandemic. Thanks to its omnichannel platforms and e-commerce presence, this retailer is already a household name in most states. In-store sales have increased 23.2% year-over-year. E-comm sales recorded an impressive 95% increase. Shares have soared approximately 290% since their March 2020 lows with the strong possibility of serious future gains.

5 Stocks Set to Double is yours free when you start 30-day access to the Zacks Investor Collection program which includes all our private long-term buys & sells for a total of $1. You may cancel at any time and there's no obligation to spend another cent.

Get started now »

Why only $1 for Zacks Investor Collection? I just want to encourage you to sample our real-time moves from stocks under $10 to home run investments to income recommendations. Plus, Zacks Premium research and tools to find and evaluate your own stocks, ETFs and mutual funds.

Please keep in mind that this opportunity is ending fast. Be sure to download the free report before midnight tonight, January 31.

Happy Investing,

Kevin Matras - signature
Sheraz Mian
Director of Research

没有评论:

发表评论